Comparison of Milrinone and Epinephrine on TAPSE

Study acronym: Milrinone
StatusRecruiting
PhaseNot applicable
Started

Free. We email you which fields changed when ClinicalTrials.gov updates this record.

Track this trial
View on ClinicalTrials.gov ↗
Trial flagged as At Risk
Primary completion moved at least 12 months later Dec 30, 2027 → Dec 30, 2028
See other at-risk trials from Mansoura University

Record History

See every version on ClinicalTrials.gov ↗

  1. Primary completion pushed from Dec 30, 2027 to Dec 30, 2028 Show 6 more changesShow less
    • Recruitment opened
    • Study completion pushed from Mar 30, 2028 to Mar 30, 2029
    • Study sites: 0 to 1
    • Eligibility criteria shortened, about 6 words
    • Secondary endpoints: details revised at 1 of 5 entries
    • Study description revised
  2. Primary completion date: Dec 30, 2026 to Dec 30, 2027
    • Start date: Oct 1, 2025 to Mar 1, 2026
    • Primary endpoint revised
    • Study completion date: Mar 30, 2027 to Mar 30, 2028
    v3
  3. Primary endpoint revised
    • Enrollment target: 100 to 102
    • Secondary endpoints: 2 to 5
    v2
  4. Study First Submitted
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
Cardiopulmonary bypass (CPB) is a critical technology in cardiac surgery, allowing for the temporary replacement of the heart and lung functions during intricate surgical procedures. it has significant post-surgical complications, the most important complications of CPB is right ventricle (RV) dysfunction. Diagnosis and management of RV dysfunction is crucial for maintenance of hemodynamic stability and organ function in early post-operation period and prognostic for later phase.
Trial Details
NCT Number NCT07144267
Lead Sponsor Mansoura University
Conditions
(from sponsor)		 Cardiac Anaesthesia, Cardiopulmonary Bypass
Enrollment 102 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov